Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

BIRMINGHAM, Ala., and ST. LOUIS , July 12, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) and BJC HealthCare today announced they have been awarded a certificate of need to build a freestanding, 40-bed inpatient rehabilitation hospital in Town and Country, Missouri.

Encompass Health and BJC HealthCare announce plans to build a 40-bed inpatient rehabilitation hospital in Town and Country, Missouri

BIRMINGHAM, Ala. , July 7, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2022, after the market closes on August 1, 2022.

Encompass Health announces date of 2022 second quarter earnings call

Enhabit Inc

Enhabit also announces two new appointments to its board of directors DALLAS , July 1, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporation. Enhabit will begin trading regular way on the New York Stock Exchange this morning, July 1, 2022, under the ticker symbol "EHAB.

Enhabit Home Health & Hospice Completes Spin-off from Encompass Health

BIRMINGHAM, Ala. , July 1, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) ("Encompass Health"), today announced that it has completed the spin off of 100% of Enhabit, Inc. ("Enhabit"), its home health and hospice business.

Encompass Health Corporation Completes Spin Off of Enhabit Home Health & Hospice

Stride

Neenah

Ormat Technologies

S&P Global

Schweitzer-Mauduit

Southwestern Energy

NEW YORK , June 28, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices: S&P SmallCap 600 constituent Omnicell Inc (NASD: OMCL) will replace Coherent Inc. (NASD: COHR) in the S&P MidCap 400, and Stride Inc (NYSE: LRN) will replace Omnicell in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 5. S&P MidCap 400 constituent II-VI Inc. (NASD: IIVI) is acquiring Coherent in a deal expected to be completed on July 1, pending final closing conditions.

Omnicell, Southwestern Energy and Ormat Technologies Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

Encompass Health (EHC) takes its U.S. inpatient rehabilitation hospital count to 150 with the opening of a hospital in Florida integrated with the sound EHR system of Oracle Cerner.

Encompass Health (EHC) Opens EHR-Backed Hospital in Florida

BIRMINGHAM, Ala. , June 20, 2022 /PRNewswire/ -- This week, Encompass Health (NYSE: EHC), a national leader in integrated healthcare services company with a network of inpatient rehabilitation hospitals and home health and hospice agencies, launched its 150th post-acute inpatient rehabilitation hospital in Jacksonville, Florida, with Oracle Cerner Corporation's electronic health record (EHR) system.

ENCOMPASS HEALTH CELEBRATES LAUNCHING ITS 150TH HOSPITAL WITH ORACLE CERNER EHR

The NCH Healthcare System's board grants approval to invest in the joint venture with Encompass Health (EHC).

Encompass Health (EHC) Forms JV With NCH Healthcare in Naples

Carter's

Pool

Tractor Supply

Jensen Investment Management follows a simple rule for initial screenings of stocks: Companies need to have achieved returns on equity (ROE) of at least 15% annually, for at least 10 consecutive years.

Four value-stock picks from a fund manager who steers clear of the energy sector

Every Encompass Health (EHC) shareholder will receive one Enhabit common share for every two EHC common shares held.

Encompass Health (EHC) Plans to Distribute Enhabit Shares

Encompass Health and NCH Healthcare System announce plan to own and operate inpatient rehabilitation hospital in Naples, Florida

Record date for the distribution of Enhabit shares will be June 24, 2022 Distribution expected to be completed on July 1, 2022 BIRMINGHAM, Ala. , June 14, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) ("Encompass Health"), today announced its board of directors has declared a distribution of all of the outstanding shares of common stock of its wholly-owned subsidiary, Enhabit, Inc. ("Enhabit"), to Encompass Health stockholders.

Encompass Health Corporation Board of Directors Declares Distribution of Enhabit Home Health & Hospice

Encompass Health (EHC) expects to retain its cash dividend routine. However, the amount might decline to reflect the spin-off of the home health and hospice business.

Encompass Health (EHC) Updates 2022 Guidance: Dips 5.4%

Encompass Health Corporation (NYSE: EHC) lowered its FY22 sales guidance from $5.38 billion - $5.50 billion to $5.33 billion - $5.42 billion, below the consensus of $5.46 billion The company forecasts adjusted EBITDA of $1.01 billion - $1.05 billion from $1.02 billion - $1.07.

Why Encompass Health Shares Are Trading Lower Today

Shares of Encompass Health Corp. dove 5.2% toward a four-month low in premarket trading Tuesday, after the health care services company cut its full-year profit and sales outlook, citing a "challenging" operating environment coupled with an expected "substantial" improvement later this year.

Encompass Health stock drops after full-year profit, sales warning

BIRMINGHAM, Ala. , June 7, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) ("Encompass Health" or the "Company"), today issued separate full-year 2022 guidance for its inpatient rehabilitation business and its home health and hospice business ("Enhabit").

Encompass Health issues full-year 2022 guidance for Encompass Health and Enhabit

Encompass Health Rehabilitation Hospital of Cape Coral, a 40-bed inpatient rehabilitation hospital, now open

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?

Encompass Health (EHC) Down 6.4% Since Last Earnings Report: Can It Rebound?

Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.

Encompass Health (EHC) Unveils Plan to Better Serve Texas

BIRMINGHAM, Ala. , May 13, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it plans to build a freestanding, 60-bed inpatient rehabilitation hospital in Houston, Texas.

Encompass Health announces plans to build a 60-bed inpatient rehabilitation hospital in Houston, Texas

BIRMINGHAM, Ala. , May 12, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will present at the UBS Global Healthcare Conference being held May 23-25, 2022 in New York City.

Encompass Health to present at UBS Global Healthcare Conference

Encompass Health Corporation (EHC) looks to unveil eight additional de novo locations this year and increase its bed count.

Why Encompass Health (EHC) is Down 2.4% Since Q1 Earnings Beat

Encompass Health Rehabilitation Hospital of Lakeland, a 50-bed inpatient rehabilitation hospital, now open

Encompass Health Corporation (NYSE:EHC ) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants Mark Miller – Chief Investor Relations Officer & Senior Vice President, Investor Relations Mark Tarr – President and Chief Executive Officer Doug Coltharp – Chief Financial Officer Barb Jacobsmeyer – Chief Executive Officer-Home Health and Hospice Conference Call Participants Kevin Fischbeck – Bank of America A.J. Rice – Credit Suisse Sarah James – Barclays Matt Larew – William Blair Andrew Mok – UBS Jack Slevin – Jefferies John Ransom – Raymond James Matthew Borsch – BMO Capital Markets Scott Fidel – Stephens Mark Miller Thank you, operator, and good morning, everyone.

Encompass Health's (EHC) CEO Mark Tarr on Q1 2022 Results - Earnings Call Transcript

TUSTIN, Calif. , April 28, 2022 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of a new location for Encompass Health Rehabilitation Hospital of Tustin , a 65-bed inpatient rehabilitation hospital.

News for Encompass Health Stock (EHC)